Finance

Lists
BAX:NYSE
Baxter International Inc
US$25,81
+0,29%
(+0,075) 1D
13 ພ.ຈ., 16 ໂມງ 0 ນາທີ 03 ວິນາທີ GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAX...
Open
US$25,90
High
US$25,90
Low
US$25,43
Mkt. cap
13,35 ຕື້
Avg. vol.
6,84 ລ້ານ
Volume
0,00
Dividend
0,15%
Quarterly dividend
US$0,01
Ex-dividend date
27 ພ.ຈ. 2026
52-wk high
US$30,00
52-wk low
US$15,73
EPS
US$-1,42
Beta
0,68
Shares outstanding
517,35 ລ້ານ
No. of employees
38 ພັນ
Open
US$25,90
High
US$25,90
Low
US$25,43
Mkt. cap
13,35 ຕື້
Avg. vol.
6,84 ລ້ານ
Volume
0,00
Dividend
0,15%
Quarterly dividend
US$0,01
Ex-dividend date
27 ພ.ຈ. 2026
52-wk high
US$30,00
52-wk low
US$15,73
EPS
US$-1,42
Beta
0,68
Shares outstanding
517,35 ລ້ານ
No. of employees
38 ພັນ
News stories
From web sources and news partners
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37,5 ພັນ
Founded1931
HeadquartersDeerfield, ອິລິນອຍ, ສະຫະລັດ
SectorHealth Care
IndustryMedical device
Websitebaxter.com
Analyst ratings
Based on 7 analysts giving stock ratings to BAX in the past 3 months
Hold
Buy
0
Hold
6
Sell
1
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BAX in the last 3 months.
Highest
Current US$25,81
US$27,00 (+4,61%)
Average
US$25,00 (-3,14%)
Lowest
US$23,00 (-10,89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Steven Silver
Argus Research
Hold
Maintained
-
-
11/11/2026
Unknown Analyst
Argus Research
Hold
Maintained
-
-
11/11/2026
Christopher Pasquale
Barclays
Sell
Maintained
US$23,00
-10,9%
11/09/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
US$25,00
-3,1%
10/30/2026
Rick Wise
Stifel Nicolaus
Hold
Maintained
US$25,00
-3,1%
10/30/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
US$25,00
-3,1%
10/30/2026
Matthew Taylor
Jefferies
Hold
Maintained
US$25,00
-3,1%
10/29/2026
Matt Miksic
Barclays
Sell
Maintained
US$20,00
-22,5%
10/07/2026
Joanne Wuensch
Citi
Hold
Maintained
US$27,00
+4,6%
10/05/2026
Travis Steed
Bank of America Securities
Hold
Maintained
US$28,00
+8,5%
08/11/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
US$27,00
+4,6%
07/31/2026
Josh Jennings
TD Cowen
Hold
Maintained
US$29,00
+12,4%
07/31/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
US$23,00
-10,9%
07/31/2026
Danielle Antalffy
UBS
Hold
Reiterated
US$25,00
-3,1%
07/28/2026
Patrick Wood
UBS
Hold
Reiterated
US$25,00
-3,1%
07/28/2026
David Roman
Goldman Sachs
Hold
Reiterated
US$21,00
-18,6%
07/15/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
US$24,00
-7%
07/06/2026
Last report
29 ຕ.ລ. 2026
Fiscal period
Q3 2026
US$0,58 / US$0,52
+11,92%beat
Revenue / Est. (USD)
2,98 ຕື້ / 2,91 ຕື້
+2,33%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
ກ.ຍ. 2026
Revenue
2,97 ຕື້
2,70 ຕື້
2,96 ຕື້
2,98 ຕື້
Cost of goods sold
2,01 ຕື້
1,80 ຕື້
1,99 ຕື້
1,93 ຕື້
Cost of revenue
2,01 ຕື້
1,80 ຕື້
1,99 ຕື້
1,93 ຕື້
Research and development expenses
116,00 ລ້ານ
124,00 ລ້ານ
125,00 ລ້ານ
118,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
675,00 ລ້ານ
658,00 ລ້ານ
693,00 ລ້ານ
680,00 ລ້ານ
Operating expense
741,00 ລ້ານ
740,00 ລ້ານ
766,00 ລ້ານ
750,00 ລ້ານ
Total operating expenses
2,76 ຕື້
2,54 ຕື້
2,75 ຕື້
2,68 ຕື້
Operating income
219,00 ລ້ານ
158,00 ລ້ານ
207,00 ລ້ານ
294,00 ລ້ານ
Other non operating income
3,00 ລ້ານ
-1,00 ລ້ານ
1,00 ລ້ານ
-1,00 ລ້ານ
EBT including unusual items
-756,00 ລ້ານ
-6,00 ລ້ານ
158,00 ລ້ານ
417,00 ລ້ານ
EBT excluding unusual items
161,00 ລ້ານ
88,00 ລ້ານ
144,00 ລ້ານ
227,00 ລ້ານ
Income tax expense
279,00 ລ້ານ
11,00 ລ້ານ
23,00 ລ້ານ
119,00 ລ້ານ
Effective tax rate
-36,90%
-183,33%
14,56%
28,54%
Other operating expenses
-50,00 ລ້ານ
-42,00 ລ້ານ
-52,00 ລ້ານ
-48,00 ລ້ານ
Net income
-1,13 ຕື້
-15,00 ລ້ານ
126,00 ລ້ານ
294,00 ລ້ານ
Net profit margin
-37,93%
-0,56%
4,26%
9,88%
Earnings per share
0,44
0,36
0,56
0,58
Interest and investment income
11,00 ລ້ານ
12,00 ລ້ານ
13,00 ລ້ານ
13,00 ລ້ານ
Interest expense
-69,00 ລ້ານ
-78,00 ລ້ານ
-77,00 ລ້ານ
-74,00 ລ້ານ
Net interest expenses
-58,00 ລ້ານ
-66,00 ລ້ານ
-64,00 ລ້ານ
-61,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
459,00 ລ້ານ
395,00 ລ້ານ
446,00 ລ້ານ
533,00 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
ແອັບຂອງ Google